
|Videos|February 8, 2023
The Role of Teclistamab in Multiple Myeloma
Dr Ajai Chari explains the mechanism of action of BCMA-targeting bispecifics and the role of teclistamab in multiple myeloma treatment.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?
2
Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer
3
Why CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma
4
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
5




























































